Interventions in Mathematics and Cognitive Skills
Launched by STANFORD UNIVERSITY · Jan 7, 2022
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring how certain interventions can help children improve their math skills, especially those who struggle with math learning disabilities (MLD). The researchers want to understand the brain processes that occur when kids receive help with their numerical skills. They are looking for elementary school-aged children, between 6 to 12 years old, who either have difficulties in math or are typically developing and perform well in math. To participate, children must have a certain level of intelligence and must not have any serious neurological or psychiatric conditions.
If your child is eligible and decides to take part, they will engage in activities designed to enhance their math abilities. The trial may also involve brain scans to learn more about how their brains respond to these interventions. It’s important to note that children with a history of head injuries or certain medical conditions may not be able to participate. The study is currently recruiting participants, so if you think your child might qualify, it could be a great opportunity to help them improve their math skills while contributing to important research.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Elementary school aged children starting from first grade (6-12 years old)
- • 2. IQ: Participants with a Full Scale IQ \> 70 on the Wechsler Abbreviated Scle of Intelligence (WASI-II).
- • 3. Identification of Mathematical Learning Disabilities: Scores below the 35th percentile percentile on symbolic number processing test in Numeracy Screener and two or more Wechsler Individual Achievement Test (WIAT-IV) math subtests
- • 4. Identification of typically developing children: Scores at or above the 35th percentile percentile on symbolic number processing test in Numeracy Screener and all WIAT-IV math subtests
- • 5. Normal or corrected-to-normal vision and no hearing impairments
- • 6. Inclusion in MRI scan session: Right-handed
- Exclusion Criteria:
- • 1. History of neurological or psychiatric disorder (i.e., schizophrenia, psychosis, depression, or attention deficit hyperactivity disorder.)
- • 2. History of trauma involving head injury
- • 3. Consistent psychiatric medications
- • 4. Exclusion from MRI scan session: No major contraindication for magnetic resonance imaging (MRI) - braces, metal implants, pacemakers, vascular stents, metallic ear tubes, consistent exposure to metal, claustrophobia)
About Stanford University
Stanford University is a prestigious academic institution renowned for its cutting-edge research and innovation in healthcare and medicine. As a clinical trial sponsor, Stanford leverages its extensive resources, including a collaborative network of world-class researchers and state-of-the-art facilities, to advance medical knowledge and improve patient care. The university is committed to conducting rigorous, ethical research that adheres to the highest standards of scientific integrity, fostering an environment where groundbreaking discoveries can translate into effective clinical applications. Through its clinical trials, Stanford aims to address critical health challenges and contribute to the development of novel therapies and treatment strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Palo Alto, California, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials